コンテンツへスキップ
Merck

Otitis media.

Pediatric clinics of North America (2013-03-14)
Michael E Pichichero
要旨

Acute otitis media (AOM) is diagnosed based on visualization of a full or bulging tympanic membrane with middle ear effusion. The distribution of bacteria causing AOM in North America under the influence of pneumococcal conjugate vaccination and antibiotic selection pressure has resulted in a predominance of β-lactamase-producing Haemophilus influenzae followed by penicillin-resistant Streptococcus pneumoniae. Although guidelines continue to endorse amoxicillin as the preferred treatment, amoxicillin/clavulanate in high dosage would be the preferred treatment based on the otopathogen mix currently. Antibiotic prophylaxis has fallen into disfavor as a preventative strategy for AOM recurrences.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
アモキシシリン, 95.0-102.0% anhydrous basis
Supelco
アモキシシリン 三水和物, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Cefpodoxime proxetil, United States Pharmacopeia (USP) Reference Standard
Supelco
アモキシシリン 三水和物, VETRANAL®, analytical standard
Supelco
セフロキシム, VETRANAL®, analytical standard